NY-ESO-1 is associated with an aggressive phenotype of ovarian cancer

被引：0
|
作者：
Szender, J. B. [1 ]
Papanicolau-Sengos, A. [2 ]
Eng, K. [1 ]
Miliotto, A. J. [1 ]
Lugade, A. [1 ]
Gnjatic, S. [3 ]
Matsuzaki, J. [1 ]
Odunsi, K. [1 ]
机构：
[1] Roswell Park Canc Inst, Buffalo, NY 14263 USA
[2] OmniSeq, Buffalo, NY USA
[3] Elmhurst Hosp Ctr, Icahn Sch Med Mt Sinai, Elmhurst, NY USA
来源：
GYNECOLOGIC ONCOLOGY | 2017年 / 145卷
关键词：
D O I：
10.1016/j.ygyno.2017.03.082
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
54
引用
收藏
页码：30 / 30
页数：1
相关论文
共 50 条
  • [1] NY-ESO-1 expression predicts an aggressive phenotype of ovarian cancer
    Szender, J. Brian
    Papanicolau-Sengos, Antonios
    Eng, Kevin H.
    Miliotto, Anthony J.
    Lugade, Amit A.
    Gnjatic, Sacha
    Matsuzaki, Junko
    Morrison, Carl D.
    Odunsi, Kunle
    GYNECOLOGIC ONCOLOGY, 2017, 145 (03) : 420 - 425
  • [2] NY-ESO-1 and clinicopathological features in ovarian cancer
    Topka, Charlotte R.
    ElMasri, Wafic M.
    Magyar, Clara E.
    Song, Min
    Dorigo, Oliver
    CANCER RESEARCH, 2012, 72
  • [3] Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer
    Odunsi, Kunle
    Matsuzaki, Junko
    James, Smitha R.
    Mhawech-Fauceglia, Paulette
    Tsuji, Takemasa
    Miller, Austin
    Zhang, Wa
    Akers, Stacey N.
    Griffiths, Elizabeth A.
    Miliotto, Anthony
    Beck, Amy
    Batt, Carl A.
    Ritter, Gerd
    Lele, Shashikant
    Gnjatic, Sacha
    Karpf, Adam R.
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (01) : 37 - 49
  • [4] Evaluation of persisting NY-ESO-1 immunity in patients who have previously been vaccinated with NY-ESO-1 ISCOMATIRX® or NY-ESO-1 protein alone
    Nicholaou, T
    Chen, W
    Davis, ID
    Jackson, H
    Dimopoulos, N
    Barrow, C
    Hopkins, W
    Maraskovsky, E
    Hoffman, E
    Old, LJ
    Cebon, J
    TISSUE ANTIGENS, 2005, 66 (05): : 503 - 503
  • [5] Public NY-ESO-1 specific TCRs as novel biomarkers for immune monitoring of NY-ESO-1 positive cancer patients
    Lu, Hailing
    Pollack, Seth
    Somaiah, Neeta
    Chawla, Sant
    Hwu, Patrick
    Vignali, Marissa
    Rytlewski, Julie
    Gnjatic, Sacha
    ter Meulen, Jan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [6] Expression and immunogenicity of NY-ESO-1 in colorectal cancer
    Li, Ya
    Song, Ruifeng
    Li, Xinqiang
    Xu, Feng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (06) : 3581 - 3585
  • [7] The role of the NY-ESO-1 in the prognosis of gastric cancer
    Misir, Zvonimir
    Glavcic, Goran
    Jankovic, Suzana
    Kruljac, Ivan
    Cugura-Filipovic, Jaksa
    Cimiimic, Kristina
    Ulamec, Monika
    BIOMOLECULES AND BIOMEDICINE, 2024, 24 (04): : 813 - 820
  • [8] NY-ESO-1 expression and immunogenicity in esophageal cancer
    Fujita, S
    Wada, H
    Jungbluth, AA
    Sato, S
    Nakata, T
    Noguchi, Y
    Doki, Y
    Yasui, M
    Sugita, Y
    Yasuda, T
    Yano, M
    Ono, T
    Chen, YT
    Higashiyama, M
    Gnjatic, S
    Old, LJ
    Nakayama, E
    Monden, M
    CLINICAL CANCER RESEARCH, 2004, 10 (19) : 6551 - 6558
  • [9] NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus
    Chen, Ji-Li
    Dawoodji, Amina
    Tarlton, Andrea
    Gnjatic, Sacha
    Tajar, Abdelouahid
    Karydis, Ioannis
    Browning, Judy
    Pratap, Sarah
    Verfaille, Christian
    Venhaus, Ralph R.
    Pan, Linda
    Altman, Douglas G.
    Cebon, Jonathan S.
    Old, Lloyd L.
    Nathan, Paul
    Ottensmeier, Christian
    Middleton, Mark
    Cerundolo, Vincenzo
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (06) : E590 - E601
  • [10] NY-ESO-1 Expression Is Associated with Melanoma Thickness, but Not Mortality
    Giavina-Bianchi, Mara
    Sotto, Miriam Nacagamo
    Kanashiro, Luciane
    Simpson, Andrew J.
    Giavina-Bianchi, Pedro
    Kalil, Jorge
    Festa, Cyro
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB66 - AB66
12345